Company Summary
MEGA MEGA LIFESCIENCES PUBLIC COMPANY LIMITED
Services/Commerce
SET100 / SETCLMV / SETWB
CG Report:   
 
  Data as of 26 Jan 2022  
Price (B.) 52 Week High/Low P/E (X) P/BV (X) Paid-up (MB.) Market Cap (MB.) EV (MB.) EBITDA (MB.) EV/EBITDA
45.00 56.50 / 32.25 20.89 5.25 435.93 39,234.13 42,681.25 1,956.83 16.69
News
Date/Time Subject
01 Dec 2021 17:43   Rights of Shareholders to propose agenda and to nominate candidates to be elected as Directors
15 Nov 2021 17:56   Management Discussion and Analysis Quarter 3 Ending 30 Sep 2021
15 Nov 2021 17:55   Financial Statement Quarter 3/2021 (Reviewed)
15 Nov 2021 17:55   Financial Performance Quarter 3 (F45) (Reviewed)
16 Aug 2021 18:04   Management Discussion and Analysis Quarter 2 Ending 30 Jun 2021
more

Company Profile
Address No. 120, Moo 11, Ample Tower, 9th-10th Floor, Bangna-Trad Road, Bangna Bangkok 10260
Telephone 0-2769-4222
Fax 0-2769-4244
URL www.megawecare.com
  Annual Report 2020
Establish Date 1982 Listed Date 19/11/2013
IPO Price (Baht) 17.50 @Par0.50 Baht
IPO Financial Advisory
  • KASIKORN SECURITIES PUBLIC COMPANY LIMITED
  • Par 0.50 Baht
    Last Par Change N/A

    Business
    MEGA are a leading international manufacturer and distributor of pharmaceutical, nutraceutical products and Fast Moving Consumer Goods or FMCG . Currently, MEGA are a leading distributor in developing countries with high growth trends such as Myanmar, Vietnam and Cambodia. In addition, MEGA develop, manufacture, market and sell our own market leading brands of nutraceutical products, generic prescription pharmaceutical products, and OTC products under our Mega We CareTM brand through our distribution network and third party distributors in 35 countries across the world.

    Free Float 09 Mar 2021 29 May 2020
    % /Shareholders
    38.93% 7,078 38.75% 5,301
    Foreign Shareholders 11.26% (As of 26/01/2022) Foreign Limit 100.00%
    NVDR Shareholders  10.40% (As of 26/01/2022)
    5 Yr Price Performance (Adjusted Price)
    Price Performance (Adjusted Price) Compare to Stock (%) Compare to Sector (%) Compare to Market (%)
    5 Days -7.69 -7.97 -6.86
    20 Days -13.04 -10.90 -13.37
    60 Days -2.70 5.57 -3.14
    120 Days 9.09 9.42 2.56
    YTD -10.89 -8.56 -10.12
    P/E (X) 20.89 47.50 20.63
    P/BV (X) 5.25 4.27 1.77
    Turnover Ratio (%) 0.37 0.37 1.32

    Top 10 Major Shareholders(@30 Aug 2021) Share %
    1. บริษัท ยูนิสเตรทช์ จำกัด 434,311,400 49.81
    2. บริษัท Thai NVDR Company Limited 69,015,841 7.92
    3. นาย วิเวก ดาวัน 45,982,716 5.27
    4. SOUTH EAST ASIA UK (TYPE C) NOMINEES LIMITED 16,053,100 1.84
    5. MR. PARAMJIT SINGH SAWHNEY 13,735,395 1.58
    6. STATE STREET EUROPE LIMITED 13,732,839 1.58
    7. น.ส. ดวงนภา ตงศิริ 12,883,095 1.48
    8. BNP PARIBAS SECURITIES SERVICES, LONDON BRANCH 12,237,000 1.40
    9. MINDO ASIA INVESTMENTS LIMITED 12,070,400 1.38
    10. THE BANK OF NEW YORK MELLON 8,418,207 0.97

    Management Position
    1. Mr. MECHAI VIRAVAIDYA CHAIRMAN OF BOARD OF DIRECTOR / INDEPENDENT DIRECTOR
    2. Mr. VIVEK DHAWAN CHIEF EXECUTIVE OFFICER / DIRECTOR
    3. Mr. KIRIT SHAH DIRECTOR
    4. Mr. ISHAAN SHAH DIRECTOR
    5. Miss SAMEERA SHAH DIRECTOR
    6. Mr. SHIRAZ ERACH POONEVALA DIRECTOR
    7. Mr. THOMAS ABRAHAM DIRECTOR
    8. Mr. ALAN CHI YIM KAM INDEPENDENT DIRECTOR / CHAIRMAN OF AUDIT COMMITTEE
    9. Mr. VIJAY PAUL KARWAL INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    10. Mr. THOR SANTISIRI INDEPENDENT DIRECTOR / AUDIT COMMITTEE
    Accumulated: Turnover Ratio, Value Trade/Day
    Statistics YTD
    26 Jan 2022
    2021
    30 Dec 2021
    2020
    30 Dec 2020
    Listed share (M.) 871.87  871.87  871.87 
    Market Cap (MB.) 39,234.13  44,029.41  31,169.33 
    Price (B./share) 45.00  50.50  35.75 
    BVPS (B./Share) 8.57  8.57  7.61 
    P/BV (X) 5.25  5.89  4.70 
    P/E (X) 20.89  23.45  23.13 
    Turnover Ratio (%) 7.47  153.89  61.19 
    Value Trade/Day (MB.) 185.38  240.15  71.74 
    Beta 0.46  0.56  0.86 
     
    Rate of Return YTD  2021  2020 
    Price Change (%) -10.89  41.26  37.50 
    Dividend Yield (%) 2.00  1.78  2.01 
    Payout Ratio 0.49  0.49  0.50 
    Dividend Policy Not less than 25 percent of the net profit of the Company after deduction of corporate income tax and legal reserve

    Dividend
    Operation Period Dividend/Share Unit Payment Date Type
    01 Jan 2021 - 30 Jun 2021 0.52 Baht 14 Sep 2021 Cash
    01 Jan 2020 - 31 Dec 2020 0.54 Baht 23 Apr 2021 Cash
    01 Jan 2020 - 30 Jun 2020 0.36 Baht 11 Sep 2020 Cash
    01 Jan 2019 - 31 Dec 2019 0.14 Baht 28 Apr 2020 Cash
    - 0.27 Baht 28 Apr 2020 Cash
    01 Jan 2019 - 30 Jun 2019 0.31 Baht 13 Sep 2019 Cash
    01 Jan 2018 - 31 Dec 2018 0.40 Baht 29 Apr 2019 Cash
     
    Auditor
    (Effective Until 31/12/2021)
    MRS. WILAI BURANAKITTISOPON/KPMG PHOOMCHAI AUDIT LIMITED
    MISS ORAWAN CHUNHAKITPAISAN/KPMG PHOOMCHAI AUDIT LIMITED
    MISS VILAIVAN PHOLPRASERT/KPMG PHOOMCHAI AUDIT LIMITED
    F/S Year ended 31/12
    Latest Type of Report Unqualified opinion
    Financial Data
    Statement of Financial Position (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Cash And Cash Equivalents 1,631.93 979.42 1,006.45 1,247.92 559.53
    A/R Net 2,962.72 2,703.80 2,683.91 2,716.91 2,708.16
    Inventories 3,424.39 3,544.42 3,474.67 2,855.80 2,585.93
    Current Assets 8,568.08 7,603.89 7,619.82 7,245.84 6,468.61
    PP&E Net 1,813.90 2,013.21 1,950.98 1,770.59 1,425.99
    Non-Current Assets 3,979.92 4,089.75 3,969.89 3,286.87 3,163.98
    Total Assets 12,548.00 11,693.64 11,589.71 10,532.70 9,632.59
    OD 156.19 796.07 499.49 888.31 956.40
    A/P Net 3,328.16 3,018.91 2,788.49 2,508.04 2,169.46
    Current portion of LT - - - - -
    Current Liabilities 4,659.29 4,667.10 4,261.66 4,158.17 3,774.94
    Non-Current Liabilities 394.71 370.75 349.13 199.44 133.31
    Total Liabilities 5,054.00 5,037.85 4,610.79 4,357.61 3,908.25
    Authorized Capital 436.95 436.95 436.95 436.95 436.95
    Paid-Up Capital 435.94 435.94 435.94 435.94 433.38
    Premium (Discount) on Share Capital 2,304.52 2,304.52 2,304.52 2,304.52 2,176.63
    Retained Earnings (Deficit) 5,276.34 4,320.25 4,751.59 4,041.21 3,540.08
    Treasury Stock - - - - -
    Shares Of The Company Held By Subsidiaries - - - - -
    Other Components Of Equity -549.85 -429.27 -536.41 -608.68 -470.45
     - Surplus (Deficits) - - - - -
    Shareholders' Equity 7,468.95 6,633.45 6,957.64 6,175.00 5,724.25
    Minority Interest 25.06 22.34 21.29 0.10 0.09
    more
    Statement of Comprehensive Income (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Revenue From Operations 10,870.86 9,091.64 12,589.41 11,129.78 10,341.60
    Other Income 26.65 16.74 23.61 33.93 101.88
    Total Revenues 10,897.51 9,108.38 12,613.02 11,163.72 10,443.48
    Costs 6,368.46 5,565.37 7,603.13 6,551.30 5,750.88
    Selling And Administrative Expenses 2,868.77 2,389.28 3,299.37 3,176.45 3,242.88
    Total Cost And Expenses 9,237.23 7,954.65 10,902.50 9,727.75 8,993.75
    EBITDA 1,956.83 1,350.17 1,951.38 1,525.77 1,591.76
    Depre. & Amor. 204.94 188.46 256.33 162.06 148.97
    EBIT 1,751.89 1,161.71 1,695.05 1,363.71 1,442.79
    Net Profit : Owners Of The Parent 1,450.45 965.38 1,392.65 1,138.52 1,206.01
    EPS (B.) 1.66 1.11 1.60 1.31 1.39
    more
    Statement of Cash Flow (MB.) 9M/2021 
    (01/01/21 
    -30/09/21) 
    9M/2020 
    (01/01/20 
    -30/09/20) 
    2020 
    (01/01/20 
    -31/12/20) 
    2019 
    (01/01/19 
    -31/12/19) 
    2018 
    (01/01/18 
    -31/12/18) 
    Accounting Type Consolidate Consolidate Consolidate Consolidate Consolidate
    Operating Cash Flow 2,104.67 1,260.01 1,629.43 1,495.11 919.36
    Investing Cash Flow -242.59 -614.66 -650.28 -172.47 -647.22
    Financing Cash Flow -1,287.12 -942.94 -1,222.39 -621.31 -176.96
    Net Cash Flow 574.96 -297.59 -243.24 701.33 95.18
    more
    Annualized: ROE, ROA
    Ratios 9M/2021  9M/2020  2020  2019 
    Current Ratio (X) 1.84 1.63 1.79 1.74
    ROE (%) 26.63 21.69 21.21 19.14
    ROA (%) 18.85 14.84 15.32 13.53
    D/E (X) 0.67 0.76 0.66 0.71
    Total Asset Turnover (X) 1.19 1.11 1.14 1.11
    Gross Profit Margin (%) 41.42 38.79 39.61 41.14
    EBIT Margin (%) 16.08 12.75 13.44 12.22
    Net Profit Margin (%) 13.27 10.57 11.01 10.20

    Information only PP, PO, XR and XD
    Capital Movement (Last 3 Year)
    Date CA Type Changed paid up share Paid up share Par
    No Information Found

    Growth Rate (%) 9M/2021  9M/2020  2020  2019 
    Sales Growth 19.57 12.55 13.11 7.62
    COGs Growth 14.43 16.92 16.06 13.92
    Total Revenue Growth 19.64 12.40 12.98 6.90
    Total Expense Growth 16.12 11.15 12.08 8.16
    Net Profit Growth 50.25 27.66 22.32 -5.60

    Annualized
    Cash Cycle 9M/2021  9M/2020  2020  2019 
    A/R Turnover (Times) 5.29 4.54 4.66 4.10
    Avg. Collection Period (Days) 69.04 80.48 78.29 88.96
    Inventory Turnover (Times) 2.41 2.32 2.40 2.41
    Avg. Inventory Period (Days) 151.29 157.16 151.95 151.59
    A/P Turnover (Times) 2.96 2.73 2.87 2.80
    Avg. Payment Period (Days) 123.42 133.76 127.13 130.30
    Cash Cycle (Days) 96.91 103.88 103.11 110.25


    Trading Sign (Latest)
    Trading Alert Posted Date Lifted Date
    No Information Found

    Market Alert (Latest)
    No Information Found
    more

    Only Preferred Share and Warrants
    Other Securities
    Securities Name -

    Remark - Calculated from adjusted price
      - Presented and calculated from the consolidated statement and displayed as cumulative quarterly statement by fiscal year (Company statement will be presented and calculated incase consolidated statement is not available.)
      - The information is quarterly updated within 7 business days after the new financial statement is submitted.
      -
     
    Information on the financial statements is presented according to the information that the listed companies submit on that period. The investors should study additional information from the companies' financial statements since some companies may restate the comparing financial statements on the latest financial statements.
    Source: www.set.or.th (Copyright © The Stock Exchange of Thailand)
    The materials and information on this site are provided for informative and educational purpose only, and do not constitute or form a part of any advice or recommendation regarding any securities. The Stock Exchange of Thailand has no responsibility for the accuracy, suitability and completeness of any information, materials, statements, figures, reports or opinions provided, and has no responsibility for any losses and damages in any cases. In case you have any inquiries or clarification regarding this summary, please directly contact the listed company who made this summary.